FrontPage is India's Stock Market Social Network
Join 50,000+ Traders and Investors
forum

SUVEN Share Price Discussion

Suven Life Sciences Ltd.
NSE: SUVEN | BSE: 530239 | ISIN: INE495B01038 | Sector: Pharmaceuticals and health care

SUVEN Rating

4.7/5 (7 Ratings)
SUVEN Share Price *
53.7 +2.55 (4.99%)
* (quote may be delayed)
Find answers to all your questions on live SUVEN message board: Is SUVEN buy or sell? Should I buy SUVEN shares? Why are SUVEN shares falling? Should I invest in SUVEN stock?

You can also check SUVEN share price target recommended by brokerages.

SUVEN Discussion Forum

@newsbot • Reputation: 2,308
Suven Life share price locked at upper circuit on potential sale of CRAMS biz
There were pending buy orders of 189,223 shares, with no sellers available.
Moneycontrol
Like
reply
Reply
@newsbot • Reputation: 2,308
Exclusive | Suven Life Sciences puts demerged CRAMS arm on the block, engages Barclays as sale adviser
According to its 2019 annual report, Suven Life Sciences posted total revenues of around Rs 688 crores and a net profit of around Rs 150 crores.
Moneycontrol
Like
reply
Reply

SUVEN - 547342
कोई बताओ भाई यार की सुवेन को क्या हो गया।।। मै इसमें निवेशित हूं। 😭😭😭
Like
reply
Reply (14)
Latest replies
Krishan @krishan-r1xS24NxL
Jan 22 4:46 AM

फिर भी youtube पर demerger पर काफी वीडियो बने हुए है
Krishan @krishan-r1xS24NxL
Jan 22 4:46 AM

Youtube पर सर्च करो
Kashish @kashish-H1t2p5hx8
Jan 22 4:46 AM

Jitna i know demerger ke baad jo company nyi banti hai uske shares aapko mil jaenge... with same value.. to aapko koi loss nhi hoga...

*Suven Life Sciences De-merger Update*
 
Suven Life Sciences has demerged its CRAMS business into one of its wholly owned subsidiaries Suven Pharmaceuticals Ltd.  In consideration for the demerger, shareholders of Suven Pharma shall issue 1 share for each share of Suven Life Scie...
Read more...
1
reply
Reply (2)
Latest replies
Raj @raj-rkdBCwjrS
Jan 21 11:52 PM

Is this good news for Suven life sciences? Plz advice

Not tracking

*Suven Life Demerged Today*:
*Scheme of Arrangement (Demerger) of Suven Life Sciences Ltd. (Scrip Code 530239)*
Trading Members of the Exchange are hereby informed that, pursuant to the Scheme of Arrangement (for Demerger) approved by the Hon’ble National Company Law Tribunal, Hy...
Read more...
Like
reply
Reply
@ravikanthchopperla • Reputation: 11,889

Suven Life Sciences has demerged its CRAMS business into one of its wholly owned subsidiaries Suven Pharmaceuticals Ltd. The CRAMS business is one of the largest revenue segments for Suven, contributing to ~97% on revenues in Q2FY20.
1
reply
Reply

SUVEN - chart - 527926
Price range Target 350🙄🙄
Like
reply
Reply
@manish-rkbhGSpqS • Reputation: -26,102

6a4b4691-3a99-4c5e-a468-80e5e830e56b.pdf
280 KB

Like
reply
Reply
@invictotrader • Reputation: 2,665

SUVEN receives EIR from US FDA for its Pashamylaram facility
Like
reply
Reply
@databot • Reputation: 2,050

Kotak Securities target on SUVEN
Date: 03-Dec-19 Broker: Kotak Securities Price @ Call: 273.67 Target: 391 Recommendation: BUY
1
reply
Reply
@invictotrader • Reputation: 2,665

Suven Life share price plunges 19% after Alzheimer molecule disappoints in Phase 2 The triple therapy of Masupirdine (SUVN-502) with Donepezil and Memantine proof of concept phase 2 study missed its pre-specified primary endpoint.
Like
reply
Reply
@nishantshah91 • Reputation: 3,415

#SUVEN LIFESCIENCES
Suven’s molecule SUVN-502 did not meet pre-specified primary endpoints in Phase 2 study 🙁
Was being studied for Alzheimer’s disease
If outcome would have been positive, it could have been an out licensing opportunity for co
Like
reply
Reply
@databot • Reputation: 2,050

Geojit Financial Services target on SUVEN
Date: 21-Nov-19 Broker: Geojit Financial Services Price @ Call: 299.39 Target: 360 Recommendation: BUY
Like
reply
Reply

SUVEN - 451971
Suven Life Science Fundamental View ( taken from internet)
1
reply
Reply (2)
Latest replies

I have also this. With sl 217 lokking for tgt 430 and above this 600-850 and final targeting 1100 in long term .
Should I keep na sir. 😊

I am in profit with 11% now. 🙏🤑
@ENRITCHansraj • Reputation: -165,937
Hansraj pandey in SUVEN
BUY SUVEN 320-325 STOP LOSS 315 TARGET 330...

🎯🎯SUVEN. Lfy first target done made a 334💪💪💪
Like
reply
Reply
@ENRITCHansraj • Reputation: -165,937

BUY SUVEN 320-325 STOP LOSS 315 TARGET 330/340++
Like
reply
Reply
@guptan • Reputation: 3,172

SUVEN - chart - 439529
SUVEN
Like
reply
Reply
@TTA • Reputation: 23,829

*Suven Life Sciences Ltd. | CMP Rs. 310 | M Cap Rs. 3946 Cr | 52 W H/L 310/183*
Result is above expectations
Revenue from Operations came at Rs. 274.3 Cr (37.9% QoQ, 206.4% YoY) vs expectation of Rs. 157.7 Cr, QoQ Rs. 199 Cr, YoY Rs. 89.5 Cr
EBIDTA came at Rs. 110.5 Cr (22.8% QoQ...
Read more...
Like
reply
Reply (2)
Latest replies
Bala @bala-r1vL3tFqr
Nov 15 2:07 AM

Today intra day boomed like anything
TTA @TTA
Nov 15 2:07 AM

Yes
Intraday Cash Trades in SUVEN
Buy-306.50 T-312 Sl-300

SUVEN - 438991

Like
reply
Reply
@ShoyabHafeji • Reputation: 1,144
HALAL INVESTMENT in SUVEN
SUVEN..235 TO 322

332+
Like
reply
Reply

SUVEN LIFE
My Buy call Running from 312
After giving my call Stock Sky Rocket till 332.
Still Every dip is Opportunity to accumulate for positional tgt 370-400++
For knowing short term view on SUVEN LIFE with Technical levels ping me
Like
reply
Reply
@ravikanthchopperla • Reputation: 11,889

SUVEN LIFE SCIENCES LTD SUVP.NS SEPT-QTR CONSOL REVENUE FROM OPS 2.74 BLN RUPEES VS 895.2 MLN RUPEES YR AGO
2
reply
Reply
@ShoyabHafeji • Reputation: 1,144
HALAL INVESTMENT in SUVEN
SUVEN LIFE...235.50 BUY RANGE 232/225 PUT 218 A...

SUVEN..235 TO 322
Like
reply
Reply
@neeraj • Reputation: 1,526

Suven above 310 now. showing strong uptrend
Like
reply
Reply (3)
Latest replies
Neeraj Puri Goswami @neeraj
Nov 14 7:09 PM

Suven now touched 315. uptrend suggested at 310
Neeraj Puri Goswami @neeraj
Nov 14 7:14 PM

Suven now touched 320. uptrend suggested at 310
Neeraj Puri Goswami @neeraj
Nov 14 7:46 PM

SUVEN made new high 332.80. it was suggested at 310
Intraday Cash Trades in SUVEN
Buy-306.50 T-312 Sl-300

SUVEN - 438656

Like
reply
Reply

Buy-306.50
T-312
Sl-300
1
reply
Reply (1)
Latest replies
Vinod raj @vinodraj
Nov 14 7:00 PM

Target achieved 😎
@ravikanthchopperla • Reputation: 11,889

SUVEN - chart - 427356
06-11-2019 12:22 Pm Technical View - Suven Life LTP 286RS # Shorter Trendline Breakout at 290Rs ...
Read more...
4
reply
Reply

SUVEN LIFE
Cmp @ 297 spot
BUY ONLY ABOVE 308
TGT 316-318-324+
SL @ at your own risk
Reminder @
If break and sustain above 324
Than showing more strength for Tgt 337
Like
reply
Reply
@newsbot • Reputation: 2,308
Suven Life gains 2% after CRISIL assigns 'A' rating to co's long-term bank facilities
CRISIL assigned 'A' rating to company's long-term bank facilities and placed on ‘Rating Watch with Positive Implications'.
Moneycontrol
Like
reply
Reply

*Buy suven Life sciences* cmp 280 SL 180 tgt Open #Inventment (15shares)
Like
reply
Reply
@tipupahan • Reputation: -2,195

INTRADAY CALL FOR 17th SEPT.
#SUVEN BUY ABOVE 295.25, SL - 290, TGT - 306 & 318
#daytrading #intraday #equity #cash
Like
reply
Reply
@ShoyabHafeji • Reputation: 1,144
HALAL INVESTMENT in SUVEN
SUVEN...285 HOLD ON

SUVEN 295+ ❣
Like
reply
Reply
@ShoyabHafeji • Reputation: 1,144
HALAL INVESTMENT in SUVEN
SUVEN 280+ HOLD ON

SUVEN...285 HOLD ON
Like
reply
Reply
@ShoyabHafeji • Reputation: 1,144
HALAL INVESTMENT in SUVEN
SUVEN HIGH 272...HOLD ON

SUVEN 280+ HOLD ON
Like
reply
Reply
@ShoyabHafeji • Reputation: 1,144
HALAL INVESTMENT in SUVEN
SUVEN...267 HOLD ON ❣

SUVEN HIGH 272...HOLD ON
Like
reply
Reply (3)
Latest replies
Dhru @dhru
Sep 10 4:58 PM

Add me your group

Sir add me too
@tipupahan • Reputation: -2,195

INTRADAY CASH CALL FOR 9TH SEPT
SUVEN BUY ABOVE 259, SL - 257, TGT - 263 & 267
1
reply
Reply (1)
Latest replies
Tipu Pahan @tipupahan
Sep 9 7:38 PM

BOTH TARGETS ARE DONE!! SUVEN FROM 159 TO 267 (RETURN 3%)
@guptan • Reputation: 3,172

SUVEN - chart - 338961
Suven
Like
reply
Reply
@ShoyabHafeji • Reputation: 1,144
HALAL INVESTMENT in SUVEN
SUVEN...250+ BK UR INVESTMENT...HOLD FREE..❣

SUVEN...267 HOLD ON ❣
Like
reply
Reply (4)
Latest replies
TAPAS GHOSH @tapasghosh
Sep 3 5:17 PM

sir Gujrat alki low 383 now 395>>>>>>
TAPAS GHOSH @tapasghosh
Sep 3 5:21 PM

399>>>>>>
TAPAS GHOSH @tapasghosh
Sep 3 7:11 PM

sir what happened nifty 170 point down
@databot • Reputation: 2,050

AnandRathi Recommendation on SUVEN
Date: 26-Aug-19 Broker: AnandRathi Price @ Call: 254.96 Target: 300 Recommendation: BUY
Like
reply
Reply
@databot • Reputation: 2,050

Geojit Financial Services Recommendation on SUVEN
Date: 27-Aug-19 Broker: Geojit Financial Services Price @ Call: 253.75 Target: 303 Recommendation: BUY
Like
reply
Reply
@newsbot • Reputation: 2,308
Buy Suven Life Sciences, target Rs 300: Anand Rathi
We raise our FY20 and FY21 estimates: of FY20 revenues 5 percent and FY21, 6 percent, and earnings 8 percent each, said research firm Anad Rathi.
Moneycontrol
Like
reply
Reply
@ShoyabHafeji • Reputation: 1,144
HALAL INVESTMENT in SUVEN
SUVEN LIFE...235.50 BUY RANGE 232/225 PUT 218 AS CBSL EXPECT TARGET 245/250+

SUVEN...250+
BK UR INVESTMENT...HOLD FREE..❣
Like
reply
Reply
@ShoyabHafeji • Reputation: 1,144
HALAL INVESTMENT in SUVEN
SUVEN LIFE...235.50 BUY RANGE 232/225 PUT 218 AS CBSL EXPECT TARGET 245/250+

SUVEN...ACHVD 1ST TARGET...❣
HIGH 247+
1
reply
Reply
@ShoyabHafeji • Reputation: 1,144

SUVEN LIFE...235.50
BUY RANGE 232/225
PUT 218 AS CBSL
EXPECT TARGET 245/250+
1
reply
Reply (1)
Latest replies

Start
@newsbot • Reputation: 2,308
Like
reply
Reply
@newsbot • Reputation: 2,308
Like
reply
Reply
@newsbot • Reputation: 2,308
Like
reply
Reply
@chaudhary • Reputation: -140

Suven Life Sciences has received US court's approval to buy assets of Rising Pharmaceuticals
Like
reply
Reply
@newsbot • Reputation: 2,308
Like
reply
Reply
@newsbot • Reputation: 2,308
Like
reply
Reply
  • SUVEN - Share Price - Fundamentals

    keyboard_arrow_down
    Market Capitalization3,321.26
    Enterprise Value3,344.9
    Price to Earnings13.52
    Price to Book Value3.34
    Return on Capital Employed0.26
    Return on Equity0.18
    Face Value1
    Dividend Yield0.01
  • SUVEN Share Price - Technicals

    keyboard_arrow_down
    SUVEN - 52 Week High₹334.7
    SUVEN - 52 Week Low₹26.95
  • SUVEN - Brokerage Reports

    keyboard_arrow_down
    DateBrokerageCallTarget
    3-Dec-19Kotak SecuritiesBuy391
    21-Nov-19Geojit Financial ServicesBuy360
    27-Aug-19Geojit Financial ServicesBuy303
    26-Aug-19AnandRathiBuy300
    29-May-19Geojit Financial ServicesHold297
    SUVEN Brokerage Price Target
  • SUVEN Share Price - Historical (₹)

    keyboard_arrow_down
    DateOpenHighLowClose
    Feb 2053.753.753.753.7
    Feb 1951.1551.1551.1551.15
    Feb 1848.7548.7548.7548.75
    Feb 1745.946.4545.146.45
    Feb 1443.2544.2540.644.25
  • SUVEN Share Price - Daily Moving Averages (DMA)

    keyboard_arrow_down
    20 Day Moving Average₹120.7
    30 Day Moving Average₹182.54
    50 Day Moving Average₹223.54
    100 Day Moving Average₹254.74
    200 Day Moving Average₹255.71
  • SUVEN - Profit And Loss

    keyboard_arrow_down
    CONSOLIDATEDMar-18Mar-17 % Change
    Revenue625543.530.15
    Operating Profit233165.350.41
    Profit Before Tax230159.360.44
    Net Income158123.470.28
  • SUVEN - Balance Sheet

    keyboard_arrow_down
    CONSOLIDATEDMar-19Mar-18 % Change
    Shareholder's Funds9948670.15
    Total Liabilities1811760.03
    Total Assets1,1751,0420.13
  • SUVEN - Cash Flow

    keyboard_arrow_down
    CONSOLIDATEDMar-18Mar-17 % Change
    Cash from Operating Activity105146.94-0.29
    Cash from Investing Activity-38-352.64-0.89
    Cash from Financing Activity-58-300.93
    Net Cash Flow9-235.71-1.04
  • SUVEN - Ratios

    keyboard_arrow_down
    CONSOLIDATEDMar-18Mar-17
    Return on Assets0.150.13
    Return on Equity0.180.17
    Return on Capital Employed0.260.21
  • SUVEN - 3 year Growth

    keyboard_arrow_down
    3 Year CAGR Growth in Revenue0.2
    3 Year CAGR Growth in Operating Profit0.46
    3 Year CAGR Growth in EBIDTA0.52
    3 Year CAGR Growth in Net Income0.45
    3 Yr CAGR Growth - Diluted EPS0.45
  • SUVEN - 5 year Growth

    keyboard_arrow_down
    5 Year CAGR Growth in Revenue1.42
    5 Year CAGR Growth in Operating Profit3.38
    5 Year CAGR Growth in EBIDTA3.72
    5 Year CAGR Growth in Net Income4.12
    3 Yr CAGR Growth - Diluted EPS3.7
  • SUVEN - Recent News

    keyboard_arrow_down
    NewsBot
    Feb 12 5:53 PM
    Suven Life share price locked at upper circuit on potential sale of CRAMS biz
    Moneycontrol
    NewsBot
    Feb 12 4:18 PM
    Exclusive | Suven Life Sciences puts demerged CRAMS arm on the block, engages Barclays as sale adviser
    Moneycontrol
    NewsBot
    Oct 17 3:28 PM
    Suven Life gains 2% after CRISIL assigns 'A' rating to co's long-term bank facilities
    Moneycontrol
    NewsBot
    Aug 26 6:08 PM
    Buy Suven Life Sciences, target Rs 300: Anand Rathi
    Moneycontrol
    NewsBot
    Jul 18 1:38 AM
    NewsBot
    Jun 13 7:28 PM
    NewsBot
    May 27 12:38 AM
    NewsBot
    Apr 15 1:13 PM
    NewsBot
    Apr 15 12:43 AM
    NewsBot
    Apr 9 5:13 PM
  • SUVEN - Related Communities

    keyboard_arrow_down
    Sun Pharmaceutical Industries Ltd. S...
    Aurobindo Pharma Ltd. Sector: Pharma...
    Biocon Ltd. Sector: Pharmaceuticals ...
    Cipla Ltd. Sector: Pharmaceuticals a...
    Dr. Reddy's Laboratories Ltd. Sector...
    Lupin Ltd. Sector: Pharmaceuticals an...
    Piramal Enterprises Ltd. Sector: Phar...
    Divi's Laboratories Ltd. Sector: Pha...
    Glenmark Pharmaceuticals Ltd. Sector...
    Strides Pharma Science Ltd. Sector: P...
SOURCE: Data from D'Market via Quandl. Intraday data delayed 15 minutes.
DISCLAIMER: Information is provided "as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed. Information herein should be regarded as a resource only and should be used at one's own risk. This is not an offer to sell or solicitation to buy any securities and FrontPage will not be liable for any losses incurred or investment(s) made or decisions taken/or not taken based on the information provided herein.